Boehringer Ingelheim Launches Updated Website

The site offers PPID resources and spring testing program details for veterinarians.

Veterinarians in search of information about pituitary pars intermedia dysfunction (PPID) can get details about the disorder, learn more about diagnosing and managing PPID and get access to the PPID testing program via the updated website. 

PPID is a progressive neurodegenerative disorder that impacts a horse’s quality of life. Formerly known as equine Cushing’s disease, early clinical signs of PPID can include, but are not limited to, changes in attitude, lethargy, recurrent infections, delayed shedding, loss of muscle mass and laminitis. 

In 2013, Boehringer Ingelheim launched a testing program to help equine veterinarians and horse owners better understand and recognize the clinical signs as well as manage the disease. Since its inception, more than 40,000 horses have been tested through the program, which is offered exclusively through veterinarians. The program is offered bi-annually, in the spring and fall. 

To access the testing program veterinarians can visit the site, create an account and enroll horses. 

Besides access to the spring testing program, which runs from March 16 – June 21, veterinarians and horse owners can access information on including but not limited to: 

  • General information about PPID 
  • Clinical signs of PPID 
  • Updates on the diagnosis and management of PPID 
  • Why and how to test for PPID 
  • PPID Research 
  • Forage testing resources 

 To learn more, visit

About Boehringer Ingelheim Animal Health USA

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock. 

As a global leader in the animal health industry and as part of the family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both.  

Boehringer Ingelheim Animal Health has deep roots in the U.S. From a start in St. Joseph, Missouri, more than 100 years ago, it has grown to encompass seven sites. Boehringer Ingelheim Animal Health’s portfolio contains widely used and well-respected vaccines, parasite-control products and therapeutics for pets, horses and livestock including NexGard®, Heartgard®, Pyramid® + Presponse®, VAXXITEK®, Ingelvac CircoFLEX® and Prascend®. 

Learn more about Boehringer Ingelheim Animal Health USA at   

©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-EQU-0081-2023